Claudin 18.2: a promising actionable target in biliary tract cancers
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell'Università e della Ricerca
This publication has 30 references indexed in Scilit:
- Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology, 2020
- Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort studyVirchows Archiv, 2019
- Anatomical, histomorphological and molecular classification of cholangiocarcinomaLiver International, 2019
- Genomic spectra of biliary tract cancerNature Genetics, 2015
- Claudins: Gatekeepers of lung epithelial functionSeminars in Cell & Developmental Biology, 2015
- Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct typeJournal of Hepato-Biliary-Pancreatic Sciences, 2014
- Treatment and Prognosis for Patients With Intrahepatic CholangiocarcinomaJAMA Surgery, 2014
- Claudin-18 Is an Early-Stage Marker of Pancreatic CarcinogenesisJournal of Histochemistry & Cytochemistry, 2011
- Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinomaVirchows Archiv, 2011
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody DevelopmentClinical Cancer Research, 2008